Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vadadustat for Anemia in NDD-CKD (PRO2TECT-CORRECTION)
NCT02648347Phase 3Completed
- Sponsor
- Akebia Therapeutics
- Start
- Dec 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by Akebia Therapeutics. Started Dec 2015; status: completed.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02648347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02648347.